New Key Statistics Module, Z-Score and F-Score
NAS:ENTA Key Ratios
Market Cap $ M | 263.06 |
Enterprise Value $ M | 79.51 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.77 |
Price/Sales | 3.60 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 71.00 |
EPS (TTM) $ | -5.45 |
Beneish M-Score | -1.23 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.75 |
EV-to-EBITDA | -0.76 |
PEG | -- |
Shares Outstanding M | 21.19 |
Net Margin (%) | -160.27 |
Operating Margin % | -170.74 |
Pre-tax Margin (%) | -164.15 |
Quick Ratio | 4.92 |
Current Ratio | 4.92 |
ROA % (ttm) | -26.23 |
ROE % (ttm) | -59.98 |
ROIC % (ttm) | -121.17 |
Dividend Yield % | -- |
Altman Z-Score | -0.43 |
ENTA Number of Guru Trades
ENTA Volume of Guru Trades
Gurus Latest Trades with NAS:ENTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ENTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Enanta Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ENTA
Total 0- 1